Pharmaceutical News and Articles

Migraine Prevention Med Might Stop 'Rebound' Headaches, Too

found that those who overused pain meds had fewer headache days when taking the migraine prevention drug atogepant (Quilipta). There is a high prevalence of pai

Sports Injuries: Your Guide to Helping Your Child Heal

Youth sports are important for the development of children and teenagers, but there s no sure way to ensure a youngster doesn t get hurt while competing.That s

Magic Mushroom's Psilocybin Is America's Most Popular Hallucinogen

0.9 of respondents said they had used psilocybin in the past month, compared to 20 who used cannabis.As recreational use has expanded, enthusiasm about using ps

CDC Strengthens RSV Vaccine Advice for Those Over 75

should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if they live in nursing h

Supreme Court Set to Allow Emergency Abortions in Idaho, For Now

not by a long shot, Alexa Kolbi-Molinas, deputy director of the American Civil Liberties Union s Reproductive Freedom Project, told the Times. Make no mistake T

Histologic Response Up With Benralizumab for Eosinophilic Esophagitis

Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not affect dysphagia symptoms, according to

Atogepant Efficacious for Patients With Chronic Migraine

For patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurolo

Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN

Echocardiography during pregnancy or early postpartum can assist in identifying women with preeclampsia at greater risk of future hypertension, according to a s

Lower Risk of ALS Seen for Men With High Levels of Physical Activity, Fitness

For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS), according to a study published on

FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)